Company intelligence / Profile preview

MiCardia

Irvine, California, United Statesaugustinesurgical.com ↗

Ownership: Private
Development stage: Commercial

Overview

MiCardia has developed a unique implantable device platform that allows intra-operative and post-operative adjustment of the mitral valve annulus to treat mitral regurgitation. The first successful human implants were reported in 2008–2009. The system enables surgical, percutaneous, and non-invasive activation to adjust cardiac anatomy dynamically after implantation. Clinical results include successful initial patient implants with ongoing development toward broader clinical use

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MiCardia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiCardia.

Explore the full profile